IL100765A0 - Vaccine composition against influenza,with synergic effects containing influenza virus core as an additive - Google Patents

Vaccine composition against influenza,with synergic effects containing influenza virus core as an additive

Info

Publication number
IL100765A0
IL100765A0 IL100765A IL10076592A IL100765A0 IL 100765 A0 IL100765 A0 IL 100765A0 IL 100765 A IL100765 A IL 100765A IL 10076592 A IL10076592 A IL 10076592A IL 100765 A0 IL100765 A0 IL 100765A0
Authority
IL
Israel
Prior art keywords
additive
vaccine composition
influenza virus
composition against
virus core
Prior art date
Application number
IL100765A
Other versions
IL100765A (en
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9409015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL100765(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of IL100765A0 publication Critical patent/IL100765A0/en
Publication of IL100765A publication Critical patent/IL100765A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The use, when preparing a vaccine composition containing a standard influenza virus vaccine, of an additive which consists of a core or core fraction of at least one influenza virus, especially a fraction containing protein M; and a vaccine composition thereby obtained. The use of said additive improves the vaccine's effectiveness.
IL10076592A 1991-01-24 1992-01-24 Vaccine composition against influenza with synergic effects containing influenza virus core as an additive IL100765A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100806A FR2671974A1 (en) 1991-01-24 1991-01-24 INFLUENZA VACCINE COMPOSITION WITH SYNERGISTIC EFFECT, CONTAINING AS AN ADDITIVE TO INFLUENZA VIRUS CORE.

Publications (2)

Publication Number Publication Date
IL100765A0 true IL100765A0 (en) 1992-09-06
IL100765A IL100765A (en) 1996-06-18

Family

ID=9409015

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10076592A IL100765A (en) 1991-01-24 1992-01-24 Vaccine composition against influenza with synergic effects containing influenza virus core as an additive

Country Status (10)

Country Link
EP (1) EP0522138B2 (en)
AT (1) ATE234861T1 (en)
AU (1) AU654699B2 (en)
CA (1) CA2078985C (en)
DE (1) DE69232962T3 (en)
FR (1) FR2671974A1 (en)
IL (1) IL100765A (en)
NZ (1) NZ241398A (en)
WO (1) WO1992013002A1 (en)
ZA (1) ZA92510B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019013A1 (en) * 1993-02-19 1994-09-01 Smithkline Beecham Corporation Influenza vaccine compositions containing 3-o-deacylated monophosphoryl lipid a
FR2723740B1 (en) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc PROCESS FOR THE PREPARATION OF INFLUENZA VIRUS ANTIGENS, ANTIGENS OBTAINED AND THEIR APPLICATIONS
AU7126998A (en) * 1997-04-16 1998-11-11 Connaught Laboratories Inc. Anti-influenza compositions supplemented with neuraminidase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (en) * 1980-06-05 1981-12-11 Synthelabo PROCESS FOR ISOLATING VIRAL GLYCOPROTETIC ANTIGENS AND APPLICATION THEREOF TO VACCINE PREPARATION
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
US5136019A (en) * 1989-05-24 1992-08-04 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
AU654699B2 (en) 1994-11-17
NZ241398A (en) 1994-08-26
EP0522138B1 (en) 2003-03-19
EP0522138A1 (en) 1993-01-13
FR2671974A1 (en) 1992-07-31
ATE234861T1 (en) 2003-04-15
DE69232962T2 (en) 2005-06-23
CA2078985A1 (en) 1992-07-25
FR2671974B1 (en) 1995-03-03
ZA92510B (en) 1992-11-25
AU1248792A (en) 1992-08-27
DE69232962T3 (en) 2007-11-08
CA2078985C (en) 2004-11-09
EP0522138B2 (en) 2007-02-14
WO1992013002A1 (en) 1992-08-06
DE69232962D1 (en) 2003-04-24
IL100765A (en) 1996-06-18

Similar Documents

Publication Publication Date Title
GR3025184T3 (en) Vaccine composition containing adjuvants.
ES2060064T3 (en) SYNERGIC MICROBICIDAL COMBINATIONS.
MY104685A (en) Substituted thiazoles and their use as fungicides.
EP0568035A3 (en) Cosmetic composition formulated with an aqueous polymer emulsion.
IL96458A0 (en) Isoxazolines,their preparation,and their use as plantprotecting agents
NO944377D0 (en) Kjölemiddelblandinger
MY109233A (en) Compositions useful in the manufacture of golfballs
SE9003665D0 (en) MORPHINE PRODRUGS
DE69202822D1 (en) Silicone modified aqueous coating composition.
AP9400621A0 (en) Influenza vaccine compositions
MX24890A (en) SYNTHETIC POLYPEPTIDE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT.
NO900612D0 (en) PRESERVATIVE FOR Aqueous Compositions.
EP1666057A3 (en) An acellular vaccine comprising Bordetella pertussis antigens
DE58902899D1 (en) 2 ', 3'-DIDEOXYPURINNUCLEOSIDE / PURINNUCLEOSIDE-PHOSPHORYLASE INHIBITOR COMBINATION THERAPY AND COMPOSITIONS THEREFOR.
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
ZA92510B (en) Vaccine composition against influenza,with synergic effects,containing influenza virus core as an additive
FI893721A0 (en) SYNERGISTIC SOFTWARE COMPOSITION AND PREPARATION INNEHAOLLANDE DENSAMMA.
AU1485192A (en) Crop-protecting compositions containing isoxazolines or isothiazolines, novel isoxazolines and isothiazolines, and their preparation
NZ226677A (en) Avian vaccine and composition against e.coli
ES2013025A6 (en) 24r-scymnol, and preparation and use thereof.
ES2069960T3 (en) AGENT OR CONCENTRATE FOR THE CONSERVATION OF WOOD AND WOODEN MATERIALS.
ZA923548B (en) Non-stinging vaccine composition
MX23878A (en) COPOLYMER CONTAINING VINYL ACETATE, COMPOSITION CONTAINING IT AND PROCEDURE FOR THE PREPARATION OF THE SAME.
DE69205045D1 (en) Preparation of 3,5-diaminobenzotrifluoride.
FI930358A (en) PREPARED POLYMER PREPARATIONS

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired